In organic chemistry, carbon-carbon bonds are created by the aldol reaction. The reaction, which was independently discovered in 1869 by the Russian scientist Alexander Borodin and in 1872 by the French chemist Charles-Adolphe Wurtz, combines two carbonyl compounds (aldehydes were employed in the initial investigations) to create a new -hydroxy carbonyl compound. These items are referred to as "aldols" since many of the compounds share the structural theme of aldehyde + alcohol. Numerous significant compounds, whether they are created artificially or naturally, include aldol structural units. The aldol reaction, for instance, has been utilised in the mass manufacture of the chemical commodity pentaerythritol and the synthesis of the heart disease medication Lipitor (atorvastatin, calcium salt). The aldol reaction combines two very straightforward compounds into one that is more complicated. Complexity is raised as a result of the production of up to two extra stereogenic centres (on the aldol adduct's carbons, shown by asterisks in the scheme below). In addition to providing high yield aldol reactions, modern approaches may control the relative and absolute configuration of these stereocenters. It is crucial to have the ability to carefully synthesise stereoisomers since they can have distinctive chemical and biological properties.
Stanislaw Dzwigaj
Sorbonne University, France
Thomas J Webster
Brown University, United States
Dai Yeun Jeong
Asia Climate Change Education Center, Korea, Republic of
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Jiri Dedecek
J Heyrovsky Institute of Physical Chemistry , Czech Republic
Vladimir G Chigrinov
Hong Kong University of Science and Technology, Russian Federation
Osman Adiguzel
Firat University, Turkey
Uday Som
Shizuoka University, Japan
Rabeharitsara Andry Tahina
GPCI-ESPA Antananarivo University, MadagascarSubmit your abstract Today
Title : Nanomaterials to fight cancer, cysts, infection, and numerous other health ailments: Human data
Thomas J Webster, Brown University, United States
Title : Application of vanadium, tantalum and chromium single-site zeolite catalysts in catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : Influence of various catalysts on H₂ enhancement and CO2 capture during syngas upgrading
Enrico Paris, CREA-IT & DIAEE, Italy
Title : Plasma deposited nanocomposite thin films as integrated catalytic systems on structured packings: Concepts and applications
Hanna Kierzkowska Pawlak, Lodz University of Technology, Poland
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model via bi-odesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The Concept and Implications of Low Carbon Green Growth
Dai Yeun Jeong, Asia Climate Change Education Center, Korea, Republic of
Title : Post-translational modifications of proteins in cardiovascular diseases
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Morphological studies of quaternary alloys
Yarub Al Douri, European Academy of Sciences, Belgium
Title : Advances in heterogeneous catalysis for green conversion of propene to aldehydes and alcohols
Ram Sambhar Shukla, CSIR-Central Salt and Marine Chemicals Research Institute (CSMCRI), India
Title : Advanced nanostructures for carbon neutrality and sustainable H₂ energy
Tokeer Ahmad, Jamia Millia Islamia, India